Specifically, on January 3, 2017, the Company received a subpoena from U.S. Department of Justice, dated December 30, 2016, requesting information relating to: (1) topics related to applicable healthcare laws for period from January 1, 2013 through the present; (2) the Company's interactions with the American Kidney Fund. The American Kidney Fund has come under accusations of steering patients away from Medicare and Medicaid programs into higher paying Affordable Care Act programs.
Request more information now by clicking here: www.faruqilaw.com/ARA. There is no cost or obligation to you.
If you invested in American Renal stock or options and would like to discuss your legal rights, visit www.faruqilaw.com/ARA. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding American Renal's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
Telephone: (877) 247-4292 or (212) 983-9330
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/american-renal-notification-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-in-excess-of-100000-investing-in-american-renal-associates-holdings-inc-to-contact-the-firm-300388111.html
SOURCE Faruqi & Faruqi, LLP